DE602005014597D1 - Peptide zur Unterscheidung von Prionen - Google Patents

Peptide zur Unterscheidung von Prionen

Info

Publication number
DE602005014597D1
DE602005014597D1 DE602005014597T DE602005014597T DE602005014597D1 DE 602005014597 D1 DE602005014597 D1 DE 602005014597D1 DE 602005014597 T DE602005014597 T DE 602005014597T DE 602005014597 T DE602005014597 T DE 602005014597T DE 602005014597 D1 DE602005014597 D1 DE 602005014597D1
Authority
DE
Germany
Prior art keywords
prions
peptides
distinguishing
distinguishing prions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005014597T
Other languages
English (en)
Inventor
Jian Zheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of DE602005014597D1 publication Critical patent/DE602005014597D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factors [FGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/968—Plasmin, i.e. fibrinolysin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
DE602005014597T 2004-09-30 2005-09-29 Peptide zur Unterscheidung von Prionen Active DE602005014597D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61453304P 2004-09-30 2004-09-30

Publications (1)

Publication Number Publication Date
DE602005014597D1 true DE602005014597D1 (de) 2009-07-09

Family

ID=35432058

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005014597T Active DE602005014597D1 (de) 2004-09-30 2005-09-29 Peptide zur Unterscheidung von Prionen

Country Status (14)

Country Link
EP (2) EP2085404B1 (de)
JP (1) JP4837353B2 (de)
KR (1) KR101355369B1 (de)
CN (1) CN1804628B (de)
AR (1) AR050965A1 (de)
AT (2) ATE432473T1 (de)
AU (1) AU2005209592B2 (de)
BR (1) BRPI0504220A (de)
CA (1) CA2518372C (de)
DE (1) DE602005014597D1 (de)
ES (2) ES2382935T3 (de)
HK (2) HK1088066A1 (de)
NZ (1) NZ542583A (de)
PT (2) PT1643252E (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1848830A4 (de) * 2005-01-13 2009-05-06 Novartis Vaccines & Diagnostic Isolierung pathogener prione
NZ594844A (en) 2005-09-09 2013-04-26 Novartis Ag Prion-specific peptoid reagents

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806627A (en) 1987-05-29 1989-02-21 Research Foundation Of Mental Hygiene Inc. Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins
US5109464A (en) * 1991-05-24 1992-04-28 Amoco Corporation Rib waveguide optimized for low loss coupling to optical fibers and method of determining same
US20010001061A1 (en) 1997-02-21 2001-05-10 Prusiner Stanley B. Assay for disease related conformation of a protein
EP0861900A1 (de) 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunologischer Nachweis von Prionen
US6617119B2 (en) 1997-02-21 2003-09-09 The Regents Of The University Of California Assay for specific strains of multiple disease related conformations of a protein
US6165784A (en) 1997-10-14 2000-12-26 The United States Of America As Represented By The Secretary Of Agriculture Antibodies for the detection of prion protein as an indication of transmissible spongiform encephalopathies
EP1194164B8 (de) 1999-06-23 2007-03-21 IDEXX Laboratories Inc Prion protein peptide und deren verwendung
US6261790B1 (en) 1999-07-15 2001-07-17 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
WO2001023425A1 (en) 1999-09-28 2001-04-05 Universität Zürich Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis
GB0014870D0 (en) * 2000-06-16 2000-08-09 King S College London Peptides
CA2413742A1 (en) 2000-06-26 2002-01-03 Universitat Zurich Prion-binding activity in serum and proteins
IL141950A0 (en) 2000-10-22 2002-03-10 Hadasit Med Res Service Diagnosis of prion diseases
US20020137114A1 (en) 2001-01-19 2002-09-26 Dirk Voelkel Method of detecting PrP protein and kits therefor
DE10107083C2 (de) * 2001-02-13 2003-02-20 Abdulgabar Salama Pentosan Polysulfat als Ligand zum Nachweis von Prionen
AU2003266801B2 (en) * 2002-12-19 2010-02-25 Ortho-Clinical Diagnostics, Inc Detection and diagnosis of transmissable spongiform encephalopathies

Also Published As

Publication number Publication date
NZ542583A (en) 2007-02-23
ATE432473T1 (de) 2009-06-15
ATE550666T1 (de) 2012-04-15
EP1643252A2 (de) 2006-04-05
JP2006105988A (ja) 2006-04-20
EP2085404A1 (de) 2009-08-05
KR20060051862A (ko) 2006-05-19
CA2518372C (en) 2013-07-09
JP4837353B2 (ja) 2011-12-14
CN1804628B (zh) 2012-03-14
AR050965A1 (es) 2006-12-06
CA2518372A1 (en) 2006-03-30
AU2005209592A1 (en) 2006-04-13
HK1088066A1 (en) 2006-10-27
AU2005209592B2 (en) 2012-07-12
HK1137764A1 (en) 2010-08-06
KR101355369B1 (ko) 2014-02-03
PT1643252E (pt) 2009-06-30
CN1804628A (zh) 2006-07-19
EP1643252B1 (de) 2009-05-27
EP2085404B1 (de) 2012-03-21
ES2324919T3 (es) 2009-08-19
BRPI0504220A (pt) 2006-05-16
EP1643252A3 (de) 2006-05-31
PT2085404E (pt) 2012-05-28
ES2382935T3 (es) 2012-06-14

Similar Documents

Publication Publication Date Title
DE602005015131D1 (de) Interleukin-15-antagonistisches peptid
ATE482281T1 (de) Plastiden transit peptide
ATE498412T1 (de) System zur abgabe von flüchtigen stoffen
DK1838341T3 (da) Vaccinesammensætning omfattende et fibronectin bindende protein eller et fibronectinbindende peptid
DK1809660T3 (da) Thymus-specifikt protein
ATE397618T1 (de) Peptidcyclisierung
DK1968623T3 (da) Bacteriocin-inducer-peptider
DE602005014597D1 (de) Peptide zur Unterscheidung von Prionen
ATE445634T1 (de) Antimikrobielle peptide
ATE419271T1 (de) Antimikrobielle peptide
GB0423974D0 (en) Proteins
GB0526019D0 (en) Peptides
GB0516527D0 (en) Peptides
EP1939286A4 (de) Neue peptide
DK1625148T3 (da) Peptidkompleks
FI20040655A (fi) Proteiini- ja peptidistabilointi
GB0422110D0 (en) Recombinant proteins
ATE541926T1 (de) Neues zellpenetrierendes peptid
SE0400275D0 (sv) New polypeptide
GB0425033D0 (en) Peptides
GB0423128D0 (en) Peptides
FI20055257A (fi) Luun proteiineja
FI20055258A0 (fi) Luun proteiineja
FI20055256A0 (fi) Luun proteiineja
IL180490A0 (en) Cyclic peptides

Legal Events

Date Code Title Description
8364 No opposition during term of opposition